These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 77918)

  • 21. Immunocytochemical discordance in localization of pregnancy specific beta-1 glycoprotein, alpha-fetoprotein and human chorionic gonadotropin in testicular cancers.
    Javadpour N; Utz M; Soares T
    J Urol; 1980 Nov; 124(5):615-6. PubMed ID: 6161257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
    van der Gaast A; Hoekstra JW; Croles JJ; Splinter TA
    J Urol; 1991 Apr; 145(4):829-31. PubMed ID: 1706441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: correlation with tumor markers alpha-fetoprotein and human chorionic gonadotropin.
    Fottner C; Sattarova S; Hoffmann K; Spöttl G; Weber MM
    Eur J Endocrinol; 2008 Sep; 159(3):317-27. PubMed ID: 18524796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biologic tumor markers in management of testicular and bladder cancer.
    Javadpour N
    Urology; 1978 Aug; 12(2):177-83. PubMed ID: 80871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor markers in testicular cancer.
    Catalona WJ
    Urol Clin North Am; 1979 Oct; 6(3):613-28. PubMed ID: 92089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of serial measurement of both human chorionic gonadotropin and alpha-fetoprotein for monitoring germinal cell tumors.
    Perlin E; Engeler JE; Edson M; Karp D; McIntire KR; Waldmann TA
    Cancer; 1976 Jan; 37(1):215-9. PubMed ID: 55299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro synthesis of alpha-fetoprotein and human chorionic gonadotropin in testicular cancer.
    Javadpour N; Soares T; Princler GL
    Cancer; 1982 Jan; 49(2):303-7. PubMed ID: 6172191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring of patients with non-seminomatous germ cell tumors of the testis by determination of alpha-fetoprotein and beta-human chorionic gonadotropin levels and by computed tomography.
    Kausitz J; Ondrus D; Belan V; Matoska J
    Neoplasma; 1992; 39(6):357-61. PubMed ID: 1283444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of alpha-fetoprotein and human chorionic gonadotropin in seminoma.
    Javadpour N; McIntire KR; Waldmann TA; Bergman SM
    J Urol; 1978 Dec; 120(6):687-90. PubMed ID: 83391
    [No Abstract]   [Full Text] [Related]  

  • 30. Discordance of human chorionic gonadotropin and alpha-fetoprotein in testicular teratocarcinomas.
    Braunstein GD; McIntire KR; Waldmann TA
    Cancer; 1973 May; 31(5):1065-8. PubMed ID: 4122298
    [No Abstract]   [Full Text] [Related]  

  • 31. [Significance of alpha fetoprotein and human chorionic gonadotropin determination in malignant testicular tumors].
    Cerný V; Fingerová H; Janousková M; Talas M
    Rozhl Chir; 1978 Dec; 57(12):833-8. PubMed ID: 83681
    [No Abstract]   [Full Text] [Related]  

  • 32. Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma: a prospective study.
    Javadpour N; McIntire KR; Waldmann TA
    Cancer; 1978 Dec; 42(6):2768-72. PubMed ID: 83187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discordant human chorionic gonadotropin results giving rise to inappropriate therapy in a case of testicular cancer.
    Bulger KN; Hesketh PJ; Babayan RK
    J Urol; 1989 Dec; 142(6):1574-5. PubMed ID: 2479778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunochemical determination of human chorionic gonadotropin and alpha-fetoprotein in sera and tumors of patients with testicular cancer.
    Javadpour N; McIntire KR; Waldmann TA
    Natl Cancer Inst Monogr; 1978 Dec; (49):209-13. PubMed ID: 86162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum alpha-fetoprotein and beta-human chorionic gonadotropin levels in patients with non-seminomatous germ cell testicular cancer.
    Lange PH; Hakala TR; Fraley EE
    Minn Med; 1975 Nov; 58(11):813-5. PubMed ID: 53783
    [No Abstract]   [Full Text] [Related]  

  • 36. Acclerated growth of testicular cancer after cytoreductive surgery.
    Lange PH; Hekmat K; Bosl G; Kennedy BJ; Fraley EE
    Cancer; 1980 Mar; 45(6):1498-506. PubMed ID: 6153570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marker half-life analysis as a prognostic tool in testicular cancer.
    Lange PH; Vogelzang NJ; Goldman A; Kennedy BJ; Fraley EE
    J Urol; 1982 Oct; 128(4):708-11. PubMed ID: 6183454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testis tumor markers: how accurate are they?
    deVere White R; Karian S; Hong WK; Olsson CA
    J Urol; 1981 May; 125(5):661-3. PubMed ID: 6164799
    [No Abstract]   [Full Text] [Related]  

  • 39. [Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein].
    Bassoulet J; Pabot du Chatelard P; Ricordel I; Auberget JL; Guillemot MC; Merrer J; Timbal Y
    J Urol (Paris); 1988; 94(8):393-6. PubMed ID: 2467947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum alpha fetoprotein and testicular tumors.
    N Engl J Med; 1977 Mar; 296(12):693-4. PubMed ID: 65733
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.